1040 related articles for article (PubMed ID: 9332763)
21. A favorable clinical trend is associated with CD8 T-cell immune responses to the human papillomavirus type 16 e6 antigens in women being studied for abnormal pap smear results.
Nakagawa M; Gupta SK; Coleman HN; Sellers MA; Banken JA; Greenfield WW
J Low Genit Tract Dis; 2010 Apr; 14(2):124-9. PubMed ID: 20354421
[TBL] [Abstract][Full Text] [Related]
22. Detection of human papillomavirus DNA in cytologically normal women and subsequent cervical squamous intraepithelial lesions.
Liaw KL; Glass AG; Manos MM; Greer CE; Scott DR; Sherman M; Burk RD; Kurman RJ; Wacholder S; Rush BB; Cadell DM; Lawler P; Tabor D; Schiffman M
J Natl Cancer Inst; 1999 Jun; 91(11):954-60. PubMed ID: 10359548
[TBL] [Abstract][Full Text] [Related]
23. Human papillomavirus antibody responses among patients with incident cervical carcinoma.
Wang Z; Konya J; Avall-Lundkvist E; Sapp M; Dillner J; Dillner L
J Med Virol; 1997 Aug; 52(4):436-40. PubMed ID: 9260694
[TBL] [Abstract][Full Text] [Related]
24. Human papillomavirus HPV-16, 18, 52 and 58 integration in cervical cells of HIV-1-infected women.
Cañadas MP; Videla S; Darwich L; Tarrats A; Piñol M; García-Cuyás F; Llatjos M; Alcalde C; Fernández I; Sirera G; Clotet B
J Clin Virol; 2010 Jul; 48(3):198-201. PubMed ID: 20427229
[TBL] [Abstract][Full Text] [Related]
25. Cytokine production patterns in cervical intraepithelial neoplasia: association with human papillomavirus infection.
Clerici M; Merola M; Ferrario E; Trabattoni D; Villa ML; Stefanon B; Venzon DJ; Shearer GM; De Palo G; Clerici E
J Natl Cancer Inst; 1997 Feb; 89(3):245-50. PubMed ID: 9017005
[TBL] [Abstract][Full Text] [Related]
26. Oral contraceptive use, human papillomavirus infection, and risk of early cytological abnormalities of the cervix.
Negrini BP; Schiffman MH; Kurman RJ; Barnes W; Lannom L; Malley K; Brinton LA; Delgado G; Jones S; Tchabo JG
Cancer Res; 1990 Aug; 50(15):4670-5. PubMed ID: 2164444
[TBL] [Abstract][Full Text] [Related]
27. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
Wasik MA; Sioutos N; Tuttle M; Butmarc JR; Kaplan WD; Kadin ME
Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
[TBL] [Abstract][Full Text] [Related]
28. Serum interleukin-2 and soluble interleukin-2 receptor in gestational trophoblastic diseases.
Shaarawy M; Darwish NA; Abdel-Aziz O
J Soc Gynecol Investig; 1996; 3(1):39-46. PubMed ID: 8796806
[TBL] [Abstract][Full Text] [Related]
29. Increased secretion patterns of interleukin-10 and tumor necrosis factor-alpha in cervical squamous intraepithelial lesions.
Azar KK; Tani M; Yasuda H; Sakai A; Inoue M; Sasagawa T
Hum Pathol; 2004 Nov; 35(11):1376-84. PubMed ID: 15668895
[TBL] [Abstract][Full Text] [Related]
30. Association of HPV infection and Chlamydia trachomatis seropositivity in cases of cervical neoplasia in Midwest Brazil.
da Silva Barros NK; Costa MC; Alves RR; Villa LL; Derchain SF; Zeferino LC; Dos Santos Carneiro MA; Rabelo-Santos SH
J Med Virol; 2012 Jul; 84(7):1143-50. PubMed ID: 22585734
[TBL] [Abstract][Full Text] [Related]
31. Major sequence variants in E7 gene of human papillomavirus type 16 from cervical cancerous and noncancerous lesions of Korean women.
Song YS; Kee SH; Kim JW; Park NH; Kang SB; Chang WH; Lee HP
Gynecol Oncol; 1997 Aug; 66(2):275-81. PubMed ID: 9264576
[TBL] [Abstract][Full Text] [Related]
32. HIV-1, HIV-2, human papillomavirus infection and cervical neoplasia in high-risk African women.
Langley CL; Benga-De E; Critchlow CW; Ndoye I; Mbengue-Ly MD; Kuypers J; Woto-Gaye G; Mboup S; Bergeron C; Holmes KK; Kiviat NB
AIDS; 1996 Apr; 10(4):413-7. PubMed ID: 8728046
[TBL] [Abstract][Full Text] [Related]
33. Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.
Cuschieri KS; Cubie HA; Whitley MW; Gilkison G; Arends MJ; Graham C; McGoogan E
J Clin Pathol; 2005 Sep; 58(9):946-50. PubMed ID: 16126875
[TBL] [Abstract][Full Text] [Related]
34. HPV and cervical neoplasia: review of case-control and cohort studies.
Muñoz N; Bosch FX
IARC Sci Publ; 1992; (119):251-61. PubMed ID: 1330915
[TBL] [Abstract][Full Text] [Related]
35. Measurements of human papillomavirus transcripts by real time quantitative reverse transcription-polymerase chain reaction in samples collected for cervical cancer screening.
Lamarcq L; Deeds J; Ginzinger D; Perry J; Padmanabha S; Smith-McCune K
J Mol Diagn; 2002 May; 4(2):97-102. PubMed ID: 11986400
[TBL] [Abstract][Full Text] [Related]
36. Circulating immune profile in patients with pre-cancer and cancer of the cervix: a cross sectional study among Indian women.
Gupta MM; Jain R; Parashari A; Singh V; Sharma S
Bull Cancer; 1993 Oct; 80(10):852-6. PubMed ID: 8204922
[TBL] [Abstract][Full Text] [Related]
37. [Viral load, genomic integration frequency of human papillomavirus 16 in cervical cancer and precancerous lesions].
Li Y; Xiang Y; Zhang RF; Cai YP; Yang Y; Cheng XM; Zhu BL
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(13):906-10. PubMed ID: 21600119
[TBL] [Abstract][Full Text] [Related]
38. Pathology of the cervix.
Kjaer SK
Curr Opin Obstet Gynecol; 1992 Aug; 4(4):586-93. PubMed ID: 1324026
[TBL] [Abstract][Full Text] [Related]
39. The relationship between soluble interleukin 2 receptor levels and antidouble stranded DNA antibody levels in patients with systemic lupus erythematosus.
Ward MM; Dooley MA; Christenson VD; Pisetsky DS
J Rheumatol; 1991 Feb; 18(2):235-40. PubMed ID: 2023217
[TBL] [Abstract][Full Text] [Related]
40. Factors influencing the biological behaviour of cervical human papillomavirus (HPV) infections in prospectively followed-up women.
Syrjänen K; Mäntyjärvi R; Väyrynen M; Holopainen H; Saarikoski S; Castrén O
Arch Geschwulstforsch; 1985; 55(6):457-66. PubMed ID: 3002294
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
